Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

Thousands of men are to be checked for prostate cancer in one of the first large-scale European trials of smart screening. The pilot study, starting next week in Ireland, will combine a blood test ...

Radiotherapy to the head and neck causes temporary (or acute) side effects. Side effects can be mild or more severe, depending on the size of the area being treated and the length of your treatment.

Cardiovascular risks associated with all other available prostate cancer treatments are also discussed. Radiation-therapy-induced DNA damage in oral and rectal epithelial cells can be reduced via ...

A CT scan exposes your body to some radiation. That involves a small amount of risk, and it’s important to understand the issues. A CT scan uses what’s called “ionizing” radiation.